Stay informed about the latest advancements in science, laboratory, and research
Stay informed about the latest advancements in science, laboratory, and research Read More »
La Gazette du LABORATOIRE is a meeting and exchange point, accessible to all players in the world of Laboratories and Sciences. Created by a scientist for scientists, La Gazette du LABORATOIRE has been supporting the life of French-speaking laboratories in Research, Development, Analysis, and Control since 1995.
Discover our French edition, our Africa edition, and our websites www.gazettelabo.fr and www.LABORATOIRE.com:
La Gazette du LABORATOIRE, a human-sized team, at your service – for any questions: contact us! or call us at +33(0)4 77 72 09 65.
Want to join them as a media partner of MedFIT?
Stay informed about the latest advancements in science, laboratory, and research Read More »
BioFIT is fast approaching and we are delighted to announce the leading Life Sciences companies that will be attending the event.
Take advantage of the event to meet key players such as:
AGENT BIOTECH
ASEPTIC TECHNOLOGIES
ATLANPOLE
BIOCYTOGEN PHARMACEUTICALS
BRENUS PHARMA
CARBOGEN AMCIS
CARNOT FRANCE FUTUR ELEVAGE
CASINVENT
CEA
CER GROUPE
DEEPTOPE
DR LANG MANAGEMENT CONSULTING
EFS
FONDAZIONE TELETHON
GENFIT
HC NEXT
HTL BIOTECHNOLOGY
INVESTIR &+
IOCB TECH – XMANs
ICARE LABORATORY
LUXEMBOURG INSTITUTE OF SCIENCE & TECHNOLOGY (LIST)
MARSHALL BIORESOURCES – UTOPIA
MI:RNA
MICROSYNTH
NANOREVIV
NOVALIX
NOVAPTECH
PFIZER
PRACIPIO
PROVAXS
ROOWIN
SARTORIUS STEDIM BIOTECH
SELVITA
SERVIER
SPECIPIG
SUPERNOVA INVEST
SYNERLAB GROUP
VETOQUINOL
VIRBAC
X’PROCHEM
YES MY PATENT
ZOETIS
…and many others!
By attending BioFIT, you will have the opportunity to network with these industry leaders, learn from their experiences and explore partnership, investment and licensing opportunities.
⏰ Register before July 4th, 2024 to
benefit from the Early Bird offer!
Discover who will be attending BioFIT 2024 Read More »
BioFIT is Europe’s leading partnering event for early-stage deals and investment rounds that bring together 1,000 key players from the Life Sciences sector.
TTOs, research institutes and academia will be present together with big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors from the Life Sciences industry.
Exhibit at BioFIT to be recognised as one of these key innovation players in Life Sciences and to benefit from high visibility!
💡Present your innovative solutions to an international audience of decision-makers, investors and potential collaborators.
🤝 Maximise your networking opportunities: meet leading experts, researchers and industry professionals in the sector who can provide valuable insights, partnerships and funding opportunities.
📢Promote your organisation: by exhibiting at BioFIT, you will benefit from extensive brand visibility (mention in our printed communications, highlight on the exhibition floor plan, additional visibility on our website and on the partnering platform) and recognition as a key player in the life sciences sector.
🐤 The early bird offer is still running, so take advantage of the discounted fare before July 4th
Availability is limited and our stands are allocated on a first come, first served basis.
They already booked their stand:
Eurofins Amatsi Analytics, Carnot France Futur Élevage, Groupe Synerlab,
Microsynth, New England Biolabs, Novalix, Unither,
Wuxi AppTec, X’Prochem, Zoetis, and many others…
⏰ Book your stand before July 4th, 2024 to
benefit from the Early Bird offer!
Enhance your presence at BioFIT 2024 Read More »
As we draw closer to BioFIT 2024, we are excited to remind you of the wide range of activities and opportunities that await you at this year’s event.
BioFIT is Europe’s leading partnering event for early-stage deals and investment rounds, bringing together 1,000 innovators, investors and industry leaders from the Life Sciences sector.
Through its one-on-one meetings, conferences, pitch competition, Project – CEO matchmaking activity and exhibition area, BioFIT aims to stimulate innovation, promote biotech and pharma solutions, and shape the future of the healthcare industry.
One-on-one meetings: BioFIT’s partnering platform is your chance to forge meaningful connections that could drive your projects forward.
The partnering activity enables BioFIT’s participants to meet each other during 30-minute pre-qualified one-on-one meetings organised prior to the event.
Conference and roundtable discussions: Steered by a prestigious Committee, the BioFIT conference programme brings together bright minds to discuss the latest trends in the biotech and Life Sciences fields. A range of themed tracks will help you learn about the current issues, challenges and innovations.
Pitch sessions: BioFIT pitch sessions identify the most innovative and promising start-ups, companies, R&D projects and licensing opportunities in the Life Sciences and Animal Health sectors. Gain visibility, receive valuable feedback, and unlock opportunities for funding and partnerships.
Exhibition: The exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations, boost their visibility and generate informal meetings.
Project – CEO matchmaking: As talented CEOs are frequently sought-after by many players in the Life Sciences industry, the Project – CEO matchmaking activity aims to connect representatives of emerging start-ups, technology transfer offices, incubators and investing networks with CEOs and aspiring CEOs.
Not convinced yet?
Get a taste of BioFIT by watching last year’s aftermovie:
⏰ Register before July 4th, 2024 to
benefit from the Early Bird offer!
BioFIT 2024: Don’t miss out on our key activities Read More »
Steered by a distinguished Committee, the BioFIT conference programme brings together bright minds to discuss the latest trends in Life Sciences, to debate innovative topics, to encourage learning and generate conversations that matter.
More than 60 international experts will address current industry issues such as: the right funding sources for early-stage innovation, best practices in academia-industry R&D collaborations, winning ways to nurture early-stage assets and animal health highlights.
Tuesday, December 3rd, 2024 | 11.15 am – 12.30 pm
Pharma M&As are back, what does it mean for early-stage dealmaking?
While deal volumes have slowed in recent years, in line with overall M&A activity, deals in the life sciences sector appeared to be picking up slightly at the end of 2023. In 2024, lower valuations are expected to provide pharmaceutical companies with additional transaction and acquisition opportunities at a later stage to strengthen portfolios in the face of impending patent expiry, and at an earlier stage as part of a highly selective strategy.
Panellists will look into this seeming resurgence of M&A and its implications for early-stage deals, discussing funding availability, business development prospects and deal pattern observations.
9.45 – 10.45 am
Biotech start-ups: Which resources do you need to manage your partnership with pharma?
–
3.00 – 3.45 pm
Information is the key: What should you have ready to present your academic asset to potential industry partners?
2.00 – 3.00 pm
Long-term university-industry research programmes or alliances:
Which concrete outcomes and new developments to spark innovation?
Early-stage assets evolve in an ecosystem where TTOs, scientists and entrepreneurs are closely connected. Understanding the mechanisms and difficulties of nurturing and licensing assets is key to properly influence the valuation of assets at an early stage. How can we fully understand the proposition behind the value? How can we transform science into business more frequently and efficiently?
2.00 – 2.45 pm
Going beyond the conventional: Exploring innovative deal structures
–
4.15 – 5.00 pm
TTO to TTO collaborations: Examples and success stories of spinning off
academic assets from different institutions into a single company
9.45 – 10.45 am
Diving into the venture builder model:
Unpacking the value proposition in nurturing biotech assets
This track aims to understand the mechanisms enforcing investors’ presence in early stages of development. Are we witnessing surges of investment in specific therapeutic areas? Who are the new players involved in investing on the biotech sector and what are their pre-requisites? Are there increasing interactions and partnerships between pharma and VCs at these initial stages?
5.15 – 6.00 pm
Focus on pre-seed financing stage: What works, what doesn’t, and risks involved
11.15 am – 12.30 pm
Biotech investors’ forecast: Where will early-stage investment go in 2025?
3.15 – 4.15 pm
Asset-based vs. technology platform-based start-ups:
Analysing investors’ preferences and mechanisms in funding
This track features the latest innovation challenges in animal health R&D and intends to provide a clear understanding of the bridges that can be built between human and animal health. International experts from veterinary research and industry will discuss the latest initiatives to improve and accelerate the development of new diagnostics, vaccines and pharmaceuticals for animal diseases and beyond.
Wednesday, December 4th | 2.00 – 3.00 pm
The path to becoming a successful CEO: Tips to wanabee founders
The Project – CEO matchmaking activity aims to connect representatives of emerging start-ups, technology transfer offices, incubators and investing networks with CEOs and aspiring CEOs. It includes a dedicated visibility for projects looking for CEOs on the partnering platform and a dedicated conference around recruitment or team-building issues.
The conference programme of BioFIT 2024 is out! Read More »
Are you ready to present your groundbreaking projects and technologies to an audience of Life Sciences and Animal Health experts, investors, and potential collaborators? Then, the BioFIT pitch sessions are for you!
Scheduled for December 3rd and 4th, 2024, in Lille, BioFIT is Europe’s leading partnering event for early-stage deals and investment rounds, bringing together 1,000 innovators, investors and industry leaders from the Life Sciences sector.
Position your project in front of a diverse and influential audience
Identify and connect with potential partners who can drive your development
Receive valuable insights from Life Sciences experts to refine and improve your initiatives
Access potential funding, partnerships and collaborations that could shape the future innovation
1.Apply in the pitch sessions category that best suits your project :
If you are a young promising company seeking to raise a seed or Series A financing round
If you are a TTO, university, research institute or company with an early-stage technology looking to initiate a collaboration project and/or a licensing deal
If you have any therapeutic innovations or diagnostic solution for animal health. The Animal Health Presentations are co-organised by SIMV
2.Be selected by a jury composed of high-level representatives and international experts from public and private institutions, life sciences industries and investors
3.Pitch and be awarded : the winners will be recognised as the most innovative project or technology in the sector
Boost your innovation: BioFIT 2024 pitch sessions await! Read More »
BioFIT, leading European partnering event for early-stage deals and investment rounds, brings together 1,000 innovators, investors and industry leaders from the Life Sciences sector.
Attendees enjoy a multi-faceted experience, including one-on-one meetings, insightful conferences, a vibrant exhibition showcasing cutting-edge solutions, and engaging pitch sessions. The event provides a unique platform for collaboration and knowledge sharing.
Taking place in Lille on December 3rd and 4th and on December 11th and 12th for online meetings, BioFIT 2024 promises to be an inspiring gathering where breakthrough ideas and strategic alliances will be forged to drive the healthcare industry into the future.
Present your company, products, and expertise to a highly targeted audience in a dedicated space. This allows you to attract the attention of potential customers, partners, and stakeholders.
Exhibitors can provide live demonstrations of their products or services, allowing potential customers to see them in action.
Exhibitors have the opportunity to engage directly with attendees, including potential customers, partners and industry influencers.
The "Super Early Bird" offer runs until March 28th. Stand space will be allocated on a "first come, first served" basis, so be quick!
In 2024, BioFIT will be organised together with MedFIT, dedicated to innovation partnerships and investment rounds in the MedTech and Diagnostic sectors, as well as MEDigIT, the new European convention for Digital Health innovation.
To make sure you don’t miss out on any BioFIT 2024 news, sign up for our >> newsletter <<
BioFIT 2024, THE business convention in healthcare industry Read More »
As we step into the promising horizon of 2024, the entire BioFIT team wishes you a year of health, success and groundbreaking discoveries.
2023 was an incredible journey, and we are grateful to every member of the BioFIT community for your unwavering support, enthusiasm, and dedication to Life Sciences innovation. Together, we are improving the early-stage biotech and pharma landscapes, making meaningful connections and leading the way to a future of progress.
What awaits in 2024, for the 13th edition of BioFIT:
1. Dynamic collaborations: Prepare for a variety of tailored one-on-one meetings that foster connections and strategic alliances to drive innovation forward.
2. Insightful conferences: Engage in informative conferences that reveal the latest trends and advancements, empowering you with knowledge and foresight.
3. Vibrant exhibition: Experience a dynamic exhibition space featuring state-of-the-art solutions and encouraging collaboration between innovators and industry leaders.
4. Engaging pitch sessions: Participate in dynamic pitch sessions that provide a platform for innovative ideas to thrive, connecting visionaries with potential investors and collaborators.
🐥 Thanks to the Super Early Bird offer, running until end of March, you can benefit from very preferential rates to join the BioFIT 2024 edition.
If you’re interested in attending MedFIT and MEDigIT as well, please contact us.
✨ We are more than ready to ensure that 2024 will be rich in opportunities and collaborations.
We look forward to welcoming you to BioFIT in Lille on December 3rd & 4th, and online on December 11th & 12th, 2024.
The BioFIT event team wishes you a Happy New Year 2024 Read More »
After 2 lively days in Marseille and a day of engaging digital networking, BioFIT 2023 has come to an end, leaving us with memories of a vibrant event!
The 12th edition of BioFIT, Europe’s leading partnering event for early-stage deals and investment rounds in the Life Sciences field, took place in Marseille, on December 12th and 13th and online, on December 15th.
With 950 international participants, BioFIT 2023 brought together a wide range of key innovation players in Life Sciences, including large biotech companies, start-ups, SMEs, academic and public research institutions, technology transfer offices and seasoned investors.
Through insightful conferences, valuable networking, and cutting-edge innovations, this edition of BioFIT served to further push the boundaries of healthcare innovation.
Stay tuned for more on what came out of BioFIT 2023 and what we have in store for you in 2024.
BioFIT is back in Lille in 2024
We look forward to welcoming you to the upcoming BioFIT event in the delightful city of Lille, on December 3rd and 4th, 2024.
Register before March 28th, 2024 to
benefit from the Super Early Bird offer
⛄ The BioFIT team wishes you Happy Holidays 🎄
BioFIT 2023: An overwhelming success! Read More »
Partners: Let’s team up for Breakthroughs!
Partnerships can save lives. That’s why at Pfizer we’re eager to work with innovators to push forward great science and continually seek new partners that are actively researching bold scientific ideas, capabilities and technologies that have the potential to bring innovative treatments to patients in need. Discover Pfizer’s key areas of interest where we are looking to partner with others, and join the long history of successful partnerships with Pfizer to deliver breakthroughs that change patients’ lives
Pfizer @BioFIT 2023
Pfizer is excited to be back at BioFIT to meet new partners at our partnering booth #37.
Not registered yet for BioFIT?
Register now for a chance to meet the Pfizer team!
Pfizer is a proud sponsor of BioFIT 2023 Read More »
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Palais de la Musique et des Congrès
Place de Bordeaux
67000, Strasbourg, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.